Who Owns Abivax SA Stock?
NASDAQ: ABVXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 88.33 +0.20%
Ownership breakdown
- Held by institutions
- 72.27%
- Held by insiders
- 0.00%
- Institutional holders
- 359
- Institutions 72.3%
- Insiders 0.0%
- Public and other 27.7%
Who owns Abivax SA stock?
Institutional investors own about 72.3% of Abivax SA's shares, spread across 359 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.00% of ABVX.
The largest institutional holders are TCG Crossover Management, LLC (6.88%), Darwin Global Management, Ltd. (4.15%) and Helikon Investments Ltd (3.19%). Together, the top 10 institutions control 28.4% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their ABVX positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ABVX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| TCG Crossover Management, LLC | 6.01M | 6.88% | -7.3% |
| Darwin Global Management, Ltd. | 3.62M | 4.15% | +4.4% |
| Helikon Investments Ltd | 2.79M | 3.19% | +175.1% |
| Vestal Point Capital, LP | 2.35M | 2.69% | +56.6% |
| Jupiter Topco LLC | 1.91M | 2.19% | +100.0% |
| UBS Group AG | 1.84M | 2.11% | -59.4% |
| Adar1 Capital Management, LLC | 1.80M | 2.07% | +29.5% |
| Caligan Partners, LP | 1.56M | 1.78% | +6.6% |
| Citadel Advisors Llc | 1.44M | 1.65% | +164.2% |
| Morgan Stanley | 1.43M | 1.64% | -16.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ABVX
| Fund | Shares | % Held |
|---|---|---|
| ALGER INSTITUTIONAL FUNDS-Alger Focus Equity Fund | 607.58K | 0.70% |
| iShares Trust-iShares Biotechnology ETF | 484.80K | 0.56% |
| iShares Trust-iShares Core MSCI EAFE ETF | 480.97K | 0.55% |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 394.78K | 0.45% |
| ALGER FUNDS II-Alger Spectra Fund | 334.18K | 0.38% |
| HARBOR FUNDS-Harbor Small Cap Growth Fund | 296.56K | 0.34% |
| ALGER Inst. Fd.S-Alger Capital Appreciation Inst. Fd. | 259.98K | 0.30% |
| iShares Trust-iShares MSCI EAFE ETF | 233.21K | 0.27% |
| ALGER FUNDS-Alger Capital Appreciation Fund | 208.40K | 0.24% |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 179.10K | 0.21% |
Frequently asked questions
Who is the largest shareholder of Abivax SA?
TCG Crossover Management, LLC is the largest institutional shareholder of ABVX, owning 6.88% of shares outstanding (6.01M shares) as of its latest 13F filing.
What percentage of Abivax SA is owned by institutions?
Institutions own about 72.3% of ABVX shares and 72.3% of the public float.
How much of Abivax SA do insiders own?
Insiders, such as officers and directors, own about 0.00% of ABVX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.